Plain-English translation of NCT06880406 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying how mitochondria — the energy-producing parts of cells — work differently in people with Alzheimer's disease compared to people without it. By analyzing blood samples from patients with memory problems and healthy volunteers, scientists hope to find early clues that could help identify Alzheimer's disease before symptoms become severe. This is basic research designed to understand what goes wrong at the cellular level.
Currently, doctors can only diagnose Alzheimer's disease after memory loss has already started. This study aims to find earlier signs by looking at how cells produce energy, which may eventually lead to tests that catch the disease sooner when treatment might be more effective.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be placed in one of three groups: people with Alzheimer's disease, people with other memory disorders, or healthy volunteers. You will have blood drawn when you join the study and again one year later. The study uses blood samples you've already agreed to store, so there are no new invasive procedures beyond the standard blood draws. Your participation helps researchers understand the early cellular changes that occur in memory diseases.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
France